Loading...

Loading...

UNAM Introduces Liver-on-a-Chip, a Drug Testing Breakthrough
By Aura Moreno - Tue, 01/13/2026 - 09:02
UNAM has developed Latin America’s first liver-on-a-chip, a breakthrough for drug testing and biomedical research.
https://mexicobusiness.news/tag/chronic-disease
More Health
Scaling Precision Health: Mexico’s Functional Medicine Ecosystem
By Gustavo Rodríguez Leal - Mon, 01/05/2026 - 08:30
Scaling functional medicine in Mexico requires ecosystem models and precision health to fight chronic disease, writes Gustavo Rodríguez.
San Francisco Sues Major Processed Food Companies
By MBN Staff - Thu, 12/11/2025 - 15:14
San Francisco filed a lawsuit against 10 major food manufacturers, accusing them of causing a public health crisis.

The Invisible Insurance: Preventive Data Redefines Risk
By Emmanuelle Brunet - Thu, 12/04/2025 - 08:30
Invisible insurance is the natural transition of an industry pressured by rising costs and more demanding consumers, writes Emmanuelle Brunet.
The Fifth P: Profitable Prevention Is the Future of Healthcare
By Hector Barillas - Wed, 11/12/2025 - 06:00
If the health system only generates revenue when people get sick, who will fund a future where they don’t? Héctor Barillas examines the issue.
Mexico Raises Sugar Beverage Tax for Health Funding
By Sofía Garduño - Fri, 10/17/2025 - 10:33
Mexico will raise its sugar-sweetened beverage tax in 2026 to reduce consumption and fund nationwide preventive health programs.
Mexico Raises Sugar Beverage Tax for Health Funding
By Sofía Garduño - Thu, 09/11/2025 - 13:01
Mexico will raise its sugar-sweetened beverage tax in 2026 to reduce consumption and fund nationwide preventive health programs.
From Pipeline to Prevention: Pharma Reshapes Chronic Disease Care
By Aura Moreno - Wed, 09/10/2025 - 17:57
Pharma is transforming chronic disease care in Mexico with personalized treatments, prevention, and digital health solutions.
Mexico Launches 2025 Health, Nutrition Survey
By MBN Staff - Mon, 09/01/2025 - 17:01
Mexico’s Ministry of Health launches the 2025 National Health and Nutrition Survey to update key data for public policy decisions.
FDA Approves Wegovy for Adults with MASH, Liver Fibrosis
By Sofía Garduño - Mon, 08/18/2025 - 09:14
The US FDA approves Wegovy to treat adults with MASH and moderate to advanced liver fibrosis, excluding cirrhosis.